Literature DB >> 16804780

[Severe ocular side effects with Topamax].

V M Asensio-Sánchez1, B Torreblanca-Agüera, S Martínez-Calvo, M J Calvo, R Rodríguez.   

Abstract

CASE REPORTS: We describe 2 patients who developed ocular side effects during treatment with topiramate. One was a 16-year-old woman with generalized seizures who developed a homonymous hemianopia after using topiramate 125 mg per day for 12 weeks, and the other was a 24-year-old epileptic female who developed a bilateral maculopathy after using topiramate 150 mg per day for 8 weeks. DISCUSSION: We identified two severe ocular adverse reactions from topiramate. Both reactions necessitated discontinuing the treatment, but the topiramate-associated maculopathy was irreversible.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804780     DOI: 10.4321/s0365-66912006000600010

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  10 in total

1.  Topiramate maculopathy.

Authors:  William Gualtieri; Jan Janula
Journal:  Int Ophthalmol       Date:  2012-09-28       Impact factor: 2.031

2.  Electronegative electroretinogram associated with topiramate toxicity and vitelliform maculopathy.

Authors:  Irena Tsui; Daniel Casper; Chai Lin Chou; Stephen H Tsang
Journal:  Doc Ophthalmol       Date:  2007-10-03       Impact factor: 2.379

3.  Ocular adverse effects of Topiramate: Two case reports.

Authors:  Ananya Mandal; Suparna Chatterjee; Sagarmay Bose; Gautam Ganguly
Journal:  Indian J Pharmacol       Date:  2008-11       Impact factor: 1.200

4.  Topiramate and the vision: a systematic review.

Authors:  Mohammad-Ali Abtahi; Seyed-Hossein Abtahi; Farhad Fazel; Peyman Roomizadeh; Masoud Etemadifar; Keivan Jenab; Mojtaba Akbari
Journal:  Clin Ophthalmol       Date:  2012-01-12

5.  Topiramate-induced maculopathy in IgG4-related disease.

Authors:  Joanna DaCosta; Saad Younis
Journal:  Drug Healthc Patient Saf       Date:  2016-06-08

6.  Presumed topiramate retinopathy: a case report.

Authors:  Tiffany L M Yeung; Patrick S H Li; Kenneth K W Li
Journal:  J Med Case Rep       Date:  2016-08-01

Review 7.  Comprehensive review of visual defects reported with topiramate.

Authors:  Lisa Ford; Jeffrey L Goldberg; Fred Selan; Howard E Greenberg; Yingqi Shi
Journal:  Clin Ophthalmol       Date:  2017-05-23

8.  Case report: the role of OCT in examination of a patient with topiramate-induced acute angle closure, acute myopia and macular striae.

Authors:  Matías Osaba; Víctor Eduardo Reviglio
Journal:  Oxf Med Case Reports       Date:  2018-07-06

9.  Very High-Frequency Ultrasonography Signs in Bilateral Acute Choroidal Effusion Associated with Systemic Sulphonamide Medications: 2 Cases.

Authors:  Antonio Piñeiro Ces; Manuel Bande Rodriguez; María Rodriguez Blanco; Lourdes Peña Madrid; María J Lopez Valladares; María J Blanco Teijeiro
Journal:  Case Rep Ophthalmol       Date:  2022-02-14

Review 10.  The Ophthalmic Side Effects of Topiramate: A Review.

Authors:  Monia Mechrgui; Suleman Kanani
Journal:  Cureus       Date:  2022-08-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.